These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


379 related items for PubMed ID: 2810047

  • 1. [Electrophysiologic effects of calcium channel blockers on supraventricular tachycardia in children].
    Fujino H, Fujiseki Y, Shimada M.
    J Cardiol; 1989 Mar; 19(1):307-15. PubMed ID: 2810047
    [Abstract] [Full Text] [Related]

  • 2. The prophylaxis of AV nodal re-entry tachycardia.
    Tonkin AM, Shorne L.
    Clin Exp Pharmacol Physiol Suppl; 1982 Mar; 6():135-43. PubMed ID: 6956473
    [Abstract] [Full Text] [Related]

  • 3. [Electrophysiologic effect of a new Ca(2+)-antagonist, TA-3090 on supraventricular tachycardia and conduction system].
    Tanno K, Kobayashi Y, Miyata A, Chiyoda K, Nakagawa H, Kurano K, Kikushima S, Yazawa T, Baba T, Mukai H.
    Kokyu To Junkan; 1992 Sep; 40(9):897-902. PubMed ID: 1439290
    [Abstract] [Full Text] [Related]

  • 4. The comparative effects of diltiazem and verapamil on atrioventricular conduction and atrioventricular reentry tachycardia.
    Rowland E, McKenna WJ, Gülker H, Krikler DM.
    Circ Res; 1983 Feb; 52(2 Pt 2):I163-8. PubMed ID: 6831649
    [Abstract] [Full Text] [Related]

  • 5. Comparative electrophysiologic effects of bepridil, verapamil and diltiazem in conscious and anesthetized dogs.
    Kantelip JP, Alatienne M, Talmant JM, Ghyselinck N, Duchêne-Marullaz P.
    Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):5-18. PubMed ID: 3493741
    [Abstract] [Full Text] [Related]

  • 6. Adenosine: a clinical experience and comparison with verapamil for the termination of supraventricular tachycardias.
    Sellers TD, Kirchhoffer JB, Modesto TA.
    Prog Clin Biol Res; 1987 Nov; 230():283-99. PubMed ID: 3295883
    [Abstract] [Full Text] [Related]

  • 7. [Characteristics of action of various drugs blocking atrioventricular conduction (beta-blockers, verapamil, diltiazem) in constant fibrillation tachyarrhythmia. Is monotherapy optimal?].
    Blagova OV, Nedostup AV.
    Ter Arkh; 2006 Nov; 78(8):30-8. PubMed ID: 17078214
    [Abstract] [Full Text] [Related]

  • 8. Comparative clinical and electrophysiologic effects of adenosine and verapamil on termination of paroxysmal supraventricular tachycardia.
    Sethi KK, Singh B, Kalra GS, Arora R, Khalilullah M.
    Indian Heart J; 1994 Nov; 46(3):141-4. PubMed ID: 7821934
    [Abstract] [Full Text] [Related]

  • 9. [Electrophysiologic effects of betaxolol on conduction properties of the antegrade and retrograde pathway in patients with typical atrioventricular node reentry tachycardia following intravenous and oral administration].
    Kühlkamp V, Ickrath O, Haasis R, Seipel L.
    Z Kardiol; 1988 Aug; 77(8):527-33. PubMed ID: 3176596
    [Abstract] [Full Text] [Related]

  • 10. [Cibenzoline: electrophysiologic effects of a new class I anti-arrhythmia agents in supraventricular tachycardia].
    Pfitzner P, Manz M, Schütz R, Lüderitz B.
    Z Kardiol; 1989 Oct; 78(10):654-60. PubMed ID: 2686252
    [Abstract] [Full Text] [Related]

  • 11. Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia.
    Lim SH, Anantharaman V, Teo WS, Chan YH.
    Resuscitation; 2009 May; 80(5):523-8. PubMed ID: 19261367
    [Abstract] [Full Text] [Related]

  • 12. Electrophysiologic effects of intravenous diltiazem in patients with recurrent supraventricular tachycardias.
    Roy D, Marchand E, Chabot M, Gagné P, Waters DD, Bourassa MG.
    Can J Cardiol; 1985 May; 1(5):302-5. PubMed ID: 3842093
    [Abstract] [Full Text] [Related]

  • 13. The effects of dexmedetomidine on cardiac electrophysiology in children.
    Hammer GB, Drover DR, Cao H, Jackson E, Williams GD, Ramamoorthy C, Van Hare GF, Niksch A, Dubin AM.
    Anesth Analg; 2008 Jan; 106(1):79-83, table of contents. PubMed ID: 18165557
    [Abstract] [Full Text] [Related]

  • 14. Update on calcium-channel blocking agents.
    Talbert RL, Bussey HI.
    Clin Pharm; 1983 Jan; 2(5):403-16. PubMed ID: 6354566
    [Abstract] [Full Text] [Related]

  • 15. Effects of continuous enhanced vagal tone on dual atrioventricular node and accessory pathways.
    Chiou CW, Chen SA, Kung MH, Chang MS, Prystowsky EN.
    Circulation; 2003 May 27; 107(20):2583-8. PubMed ID: 12743004
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of heart arrhythmias with calcium antagonists].
    Bender F.
    Z Kardiol; 1984 May 27; 73 Suppl 2():101-5. PubMed ID: 6084911
    [Abstract] [Full Text] [Related]

  • 17. Electrophysiologic characteristics of verapamil-sensitive atrial tachycardia originating from the atrioventricular annulus.
    Yamabe H, Tanaka Y, Okumura K, Morikami Y, Kimura Y, Hokamura Y, Ogawa H.
    Am J Cardiol; 2005 Jun 15; 95(12):1425-30. PubMed ID: 15950564
    [Abstract] [Full Text] [Related]

  • 18. Calcium-channel blocking agents.
    Leonard RG, Talbert RL.
    Clin Pharm; 1982 Jun 15; 1(1):17-33. PubMed ID: 6764159
    [Abstract] [Full Text] [Related]

  • 19. [The phenomenon of accelerated A-V conduction. Electrophysiological study with a "selective" calcium antagonist (Verapamil)].
    Disertori M, Vergara G, Cozzi F, Inama G, Furlanello F.
    G Ital Cardiol; 1981 Jun 15; 11(4):447-57. PubMed ID: 7286518
    [Abstract] [Full Text] [Related]

  • 20. Intravenous diltiazem in patients with paroxysmal re-entrant supraventricular tachycardia.
    Frabetti L, Capucci A, Gerometta PS, Cavallini C, Leto di Priolo S, Magnani B.
    Int J Cardiol; 1989 May 15; 23(2):215-21. PubMed ID: 2722288
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.